Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Hematology|October 2, 2015
Ibrutinib in mantle cell lymphoma patients: glass half full? Evidence and opinionDeborah M Stephens, Stephen E Spurgeon
Case Reports in Hematology|September 13, 2013
Concurrent presentation of hodgkin lymphoma and multiple myelomaRekha Chandran, Miklos Simon, Stephen E Spurgeon
Leukemia & Lymphoma|January 17, 2012
Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007Rekha Chandran, Stuart K Gardiner, Miklos Simon, et al.
Cancer Genetics|December 3, 2014
Chronic lymphocytic leukemia with a FGFR3 translocation: case report and literature review of an uncommon cytogenetic eventMatthew D Geller, Ying Pei, Stephen E Spurgeon, et al.
European Journal of Haematology|October 22, 2020
A novel somatic PLCG2 variant associated with resistance to BTK and SYK inhibition in chronic lymphocytic leukemiaVikram Raghunathan, Guang Fan, Adam S Kittai, et al.
Leukemia Research Reports|January 29, 2015
Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndromeTheodore P Braun, Julia E Maxson, Anupriya Agarwal, et al.
British Journal of Clinical Pharmacology|July 1, 2021
Proapoptotic and immunomodulatory effects of SYK inhibitor entospletinib in combination with obinutuzumab in patients with chronic lymphocytic leukaemiaVi Lam, Scott Best, Adam Kittai, et al.
Investigational New Drugs|March 8, 2021
A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemiaAlexey V Danilov, Stephen E Spurgeon, Tanya Siddiqi, et al.
Leukemia & Lymphoma|June 1, 2011
Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphomaStephen E Spurgeon, Talia Pindyck, Craig Okada, et al.
Leukemia Research|December 26, 2016
CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutationMax J Gordon, Paul Tardi, Marc M Loriaux, et al.
Pageof 5